Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achiam

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 17, 2024
Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trialJakob Hedberg, Magnus Sundbom, David Edholm, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2023
Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgeryM A van Dam, O D Bijlstra, R A Faber, et al.
Science Translational Medicine|July 20, 2022
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcersRui Xu, Carsten Höß, Jakub M Swiercz, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2019
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trialRahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, et al.
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 26, 2024
Western European Variation in the Organization of Esophageal Cancer Surgical CareMaurits R Visser, Daan M Voeten, Suzanne S Gisbertz, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2021
Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter studyMichael Patrick Achiam, M Nordsmark, M Ladekarl, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 17, 2024
Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trialJakob Hedberg, Magnus Sundbom, David Edholm, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2023
Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgeryM A van Dam, O D Bijlstra, R A Faber, et al.
Science Translational Medicine|July 20, 2022
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcersRui Xu, Carsten Höß, Jakub M Swiercz, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2019
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trialRahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, et al.
Molecular Metabolism|March 12, 2021
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonistKaare V Grunddal, Thi A Diep, Natalia Petersen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 26, 2024
Western European Variation in the Organization of Esophageal Cancer Surgical CareMaurits R Visser, Daan M Voeten, Suzanne S Gisbertz, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2021
Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter studyMichael Patrick Achiam, M Nordsmark, M Ladekarl, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
Gut|November 26, 2021
International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)Melina Arnold, Eileen Morgan, Aude Bardot, et al.
Pageof 20